
Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
Some patients get more depressed on this antidepressant, but that does not mean they have bipolar disorder.